AbbVie (ABBV) Interest Expenses (2012 - 2016)

AbbVie has disclosed Interest Expenses across 5 years of filings, most recently posting $245.0 million for Q2 2016.

• In Q2 2016, Interest Expenses rose 42.44% year-over-year to $245.0 million; the TTM figure through Mar 2017 stood at $245.0 million (down 69.45% YoY), while the FY2015 annual figure was $719.0 million, up 67.6% from the prior year.
• Interest Expenses climbed to $245.0 million in Q2 2016, from $215.0 million in the prior quarter.
• Over the last five years, Interest Expenses for ABBV reached as high as $245.0 million in Q2 2016 and fell as low as $10.0 million in Q3 2012.
• The 5-year median for Interest Expenses is $113.0 million (2012), against an average of $125.8 million.
• The widest YoY moves for Interest Expenses: up 650.0% in 2013, down 21.28% in 2013.
• A 5-year view of Interest Expenses shows it stood at $94.0 million in 2012, then decreased by 21.28% to $74.0 million in 2013, then soared by 87.84% to $139.0 million in 2014, then jumped by 49.64% to $208.0 million in 2015, then advanced by 17.79% to $245.0 million in 2016.
• According to Business Quant data, Interest Expenses over the past three periods registered $245.0 million, $215.0 million, and $208.0 million for Q2 2016, Q1 2016, and Q4 2015 respectively.